About the company
Bio-Images Research Ltd., a leader and at the forefront of innovation in gamma scintigraphy, undertakes early phase clinical studies to streamline drug development processes and assist decision making.
Bio-Images Research Ltd was founded in October 2000 as a spin out company from the Universities of Strathclyde and Glasgow. Bio-Images undertakes early phase clinical studies in volunteers and patient groups, specialising in gamma scintigraphy. This non-invasive imaging technique is used to monitor oral, nasal, pulmonary and ophthalmic systems. Oral site-specific drug absorption studies are also performed using the imaGIT capsule. All studies are fully compliant with ICH-GCP guidelines with all clinical trial supplies manufactured in our in-house GMP facility.
Why use Bio-Images?
Specialist imaging techniques allow monitoring of the in vivo characteristics and behaviour of drug formulations. Accurate scintigraphic information both alone, and in combination with pharmacokinetics, will assist the pharmaceutical company in drug development decision making, including the development of new formulations as well as re-formulation of existing products, and marketing. The correct decision made at an early stage will ultimately save your company time and money. From final protocol design to issue of the clinical report, a drug delivery study can take as little as twelve weeks.
Advantages
Bio-Images offers its clients a comprehensive suite of services:
- Global capabilities
- Close links with world renowned expert consultants
- Hospital base allows access to defined patient groups and specialist medical support
- University links provide access to new technologies
- Proven track record in the development of innovative labelling techniques
- Experienced staff dedicated to quality of service
- On-site GMP manufacturing facility
- Competitive costing
Contact Bio-Images to discuss other applications of this technology and discover how we can best provide imaging solutions for your next clinical trial.
...Pushing knowledge boundaries, breaking through barriers,
innovating in partnership with our customers...